Volume 12, Number 3, March 2006

Pneumonic Plague Cluster, Uganda, 2004

Elizabeth M. Begier,* Gershim Asiki,† Zaccheus Anywaine,† Brook Yockey,‡ Martin E. Schriefer,‡ Philliam Aleti,§ Asaph Ogen-Odoi,§ J. Erin Staples,*‡ Christopher Sexton,‡ Scott W. Bearden,‡ and Jacob L. Kool‡
*Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Nyapea Hospital, Nebbi District, Uganda; ‡Centers for Disease Control and Prevention, Fort Collins, Colorado, USA; and §Uganda Virus Research Institute, Entebbe, Uganda

Figure 1. A) Grossly bloody sputum sample obtained from the surviving patient (caregiver B2) 30 h after onset of primary pneumonic plague. B) Polymerase chain reaction results of sputum sample from caregiver B2. Lanes 1–3, caf1; lanes 4–6, repA1; lanes 7–9, pla. Lanes 1, 4, and 7 are positive controls; lanes 2, 5, and 8 are patient samples; lanes 3, 6, and 9 are negative controls. C) Anti-F1 direct fluorescent antibody staining of sputum sample from caregiver B2. Numerous bacteria with classic halo structures are characteristic of Yersinia pestis. The circled bacterium classically depicts this halo.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed February 21, 2006

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention